Biotage AB (publ) Interim report January - June 2020
Challenging quarter and improved cash flowApril - June · Net sales amounted to 254.2 MSEK (282.1), a decrease by 9.9 percent and organically[*] a decrease by 12.1%. · Operating profit amounted to 24.5 MSEK (56.1). · Result after tax amounted to 32.2[1)] MSEK (54.2). · Earnings per share was 0,49[1) ]SEK (0.83) before and after dilution. · The cash flow from operating activities increased by 13.9 MSEK to 57.0 MSEK (43.1). · Net cash* at June 30 amounted to 32.1 MSEK (net debt 69.2). · Cash and cash equivalents amounted to 260.7 MSEK (185.9). · Liabilities to credit